AQR Capital Management LLC Trims Stake in Docusign Inc. $DOCU

Key Points

• AQR Capital Management LLC reduced its stake in Docusign Inc. by 18.5%, selling 230,482 shares and now holds a total of 1,015,389 shares worth approximately $82 million.
• Docusign reported earnings of $0.92 per share for the latest quarter, exceeding expectations of $0.84, with revenue reaching $800.64 million, up 8.8% year-over-year.
• Institutional investors control 77.64% of Docusign's stock, reflecting significant interest from major investment firms such as American Century and Wellington Management, which have recently increased their positions in the company.

AQR Capital Management LLC cut its stake in shares of Docusign Inc. (NASDAQ:DOCU - Free Report) by 18.5% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,015,389 shares of the company's stock after selling 230,482 shares during the period. AQR Capital Management LLC owned about 0.50% of Docusign worth $82,064,000 as of its most recent SEC filing.

Several other institutional investors have also recently made changes to their positions in DOCU. American Century Companies Inc. raised its holdings in shares of Docusign by 3.1% in the first quarter. American Century Companies Inc. now owns 5,477,758 shares of the company's stock valued at $445,890,000 after purchasing an additional 162,299 shares during the last quarter. Wellington Management Group LLP boosted its holdings in Docusign by 372.5% during the first quarter. Wellington Management Group LLP now owns 1,826,949 shares of the company's stock worth $148,714,000 after purchasing an additional 1,440,269 shares during the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its position in Docusign by 3.0% in the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 1,709,807 shares of the company's stock worth $153,780,000 after purchasing an additional 50,440 shares in the last quarter. Charles Schwab Investment Management Inc. increased its stake in Docusign by 6.7% in the 1st quarter. Charles Schwab Investment Management Inc. now owns 1,431,901 shares of the company's stock valued at $116,557,000 after buying an additional 89,948 shares during the last quarter. Finally, Pacer Advisors Inc. lifted its position in shares of Docusign by 809.6% during the 1st quarter. Pacer Advisors Inc. now owns 1,167,290 shares of the company's stock worth $95,017,000 after buying an additional 1,038,962 shares in the last quarter. Institutional investors own 77.64% of the company's stock.

Docusign Stock Down 1.5%

Docusign stock traded down $1.23 during midday trading on Wednesday, reaching $78.57. The stock had a trading volume of 3,191,954 shares, compared to its average volume of 2,667,634. The firm has a market capitalization of $15.88 billion, a PE ratio of 59.07, a P/E/G ratio of 4.72 and a beta of 1.02. Docusign Inc. has a 12 month low of $54.31 and a 12 month high of $107.86. The firm's 50-day moving average price is $75.66 and its 200 day moving average price is $79.29.

Docusign (NASDAQ:DOCU - Get Free Report) last posted its earnings results on Thursday, September 4th. The company reported $0.92 earnings per share for the quarter, topping the consensus estimate of $0.84 by $0.08. Docusign had a net margin of 9.08% and a return on equity of 14.01%. The firm had revenue of $800.64 million during the quarter, compared to the consensus estimate of $780.35 million. During the same quarter last year, the company earned $0.97 earnings per share. The company's revenue was up 8.8% on a year-over-year basis. Docusign has set its Q3 2026 guidance at EPS. FY 2026 guidance at EPS. Equities research analysts expect that Docusign Inc. will post 1.17 EPS for the current year.

Docusign announced that its Board of Directors has initiated a share repurchase program on Thursday, June 5th that permits the company to repurchase $1.00 billion in outstanding shares. This repurchase authorization permits the company to purchase up to 6.6% of its shares through open market purchases. Shares repurchase programs are usually an indication that the company's management believes its stock is undervalued.

Insider Buying and Selling

In other news, insider Robert Chatwani sold 22,875 shares of the firm's stock in a transaction on Wednesday, June 18th. The stock was sold at an average price of $74.79, for a total value of $1,710,821.25. Following the completion of the transaction, the insider directly owned 72,126 shares of the company's stock, valued at $5,394,303.54. This trade represents a 24.08% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Allan C. Thygesen sold 40,000 shares of the business's stock in a transaction on Tuesday, July 1st. The shares were sold at an average price of $77.51, for a total value of $3,100,400.00. Following the sale, the chief executive officer owned 143,983 shares in the company, valued at approximately $11,160,122.33. The trade was a 21.74% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 78,552 shares of company stock worth $5,983,631. Insiders own 1.66% of the company's stock.

Analysts Set New Price Targets

Several research firms have recently issued reports on DOCU. Wall Street Zen lowered Docusign from a "buy" rating to a "hold" rating in a report on Saturday, August 2nd. Piper Sandler boosted their price objective on Docusign from $85.00 to $90.00 and gave the stock a "neutral" rating in a research report on Friday, September 5th. JMP Securities reaffirmed a "market outperform" rating and set a $124.00 target price on shares of Docusign in a research report on Friday, September 5th. Wells Fargo & Company lifted their target price on Docusign from $80.00 to $85.00 and gave the stock an "equal weight" rating in a research note on Friday, September 5th. Finally, Royal Bank Of Canada increased their price target on shares of Docusign from $90.00 to $95.00 and gave the company a "sector perform" rating in a research report on Friday, September 5th. Four analysts have rated the stock with a Buy rating and fourteen have given a Hold rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of "Hold" and an average target price of $94.14.

About Docusign

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.